Literature DB >> 24525050

pH-controllable drug carrier with SERS activity for targeting cancer cells.

Wei Fang1, Zhuyuan Wang2, Shenfei Zong1, Hui Chen1, Dan Zhu1, Yuan Zhong1, Yiping Cui3.   

Abstract

A type of pH-controllable drug carrier is demonstrated based on mesoporous silica nanoparticles and chitosan/poly (methacrylic acid), which can simultaneously serve as the surface enhanced Raman scattering (SERS) traceable drug carriers for targeting cancer cells. The pH-sensitive releasing characteristics can be achieved by coating the nanoparticles with a layer of chitosan/poly (methacrylic acid) (CS-PMAA), while strong SERS signals can be obtained from the SERS reporter tagged Ag nanoparticles in the core. Our experimental results show that doxorubicin (DOX) was effectively encapsulated into the nanocarriers and can be released in response to the ambient pH value. Specifically, an increased amount of DOX release was observed at lower pH value. In addition, the composite nanoparticles were conjugated with transferrin (Tf) to target transferrin receptor (TfR)-overexpressed cancer cells. The targeting ability as well as the intracellular location of the drug carrier was investigated through SERS mapping while the distribution of DOX was monitored by fluorescence images. The results show that the demonstrated drug carrier can simultaneously fulfill the functionalities of pH-responsive drug release, SERS-traceable characteristics and cancer cells targeting, which has a unique potential for the pH-controllable drug delivery nanosystems.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery; Surface enhanced Raman scattering; Targeting cells; pH controllable

Mesh:

Substances:

Year:  2014        PMID: 24525050     DOI: 10.1016/j.bios.2014.01.042

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  9 in total

Review 1.  Mesoporous silica nanoparticles in nanomedicine applications.

Authors:  Miguel Manzano; María Vallet-Regí
Journal:  J Mater Sci Mater Med       Date:  2018-05-08       Impact factor: 3.896

2.  SERS-fluorescence bimodal nanoprobes for in vitro imaging of fatty acid responsive receptor GPR120.

Authors:  Lifu Xiao; Abdul K Parchur; Timothy A Gilbertson; Anhong Zhou
Journal:  Anal Methods       Date:  2017-10-18       Impact factor: 2.896

Review 3.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

4.  Functional nanovalves on protein-coated nanoparticles for in vitro and in vivo controlled drug delivery.

Authors:  Angela A Hwang; Jie Lu; Fuyuhiko Tamanoi; Jeffrey I Zink
Journal:  Small       Date:  2014-09-05       Impact factor: 13.281

Review 5.  Smart Mesoporous Nanomaterials for Antitumor Therapy.

Authors:  Marina Martínez-Carmona; Montserrat Colilla; Maria Vallet-Regí
Journal:  Nanomaterials (Basel)       Date:  2015-11-06       Impact factor: 5.076

Review 6.  Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights.

Authors:  María Vallet-Regí; Montserrat Colilla; Isabel Izquierdo-Barba; Miguel Manzano
Journal:  Molecules       Date:  2017-12-25       Impact factor: 4.411

Review 7.  Gold Nanoparticles: A Powerful Tool to Visualize Proteins on Ordered Mesoporous Silica and for the Realization of Theranostic Nanobioconjugates.

Authors:  Marco Piludu; Luca Medda; Maura Monduzzi; Andrea Salis
Journal:  Int J Mol Sci       Date:  2018-07-08       Impact factor: 5.923

8.  Effect of Poly(methacrylic acid) on the Cytokine Level in an In Vivo Tumor Model.

Authors:  Olga V Zhukova; Evgenia V Arkhipova; Tatiana F Kovaleva; Daria A Zykova; Natalya A Dubovskaya
Journal:  Molecules       Date:  2022-07-18       Impact factor: 4.927

9.  Bioceramics: from bone substitutes to nanoparticles for drug delivery.

Authors:  María Vallet-Regí
Journal:  Pure Appl Chem       Date:  2019-01-29       Impact factor: 2.453

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.